Andrew Kruse, Ph.D.
Andrew C. Kruse, Ph.D., is an Assistant Professor of Biological Chemistry and Molecular Pharmacology at Harvard Medical School. Prior to joining the faculty at Harvard, he completed doctoral training with Brian Kobilka at Stanford University, where he studied neurotransmitter receptor structure, function and pharmacology.
Andrew’s research seeks to explain the molecular basis of membrane protein signaling using biophysical techniques and structural biology, which complement more traditional cell-biological approaches. He is focused on the study of proteins important in human health and disease, with a particular emphasis on leveraging recent advances in cell signaling to develop new and better therapeutics.
An honors graduate in Biochemistry and Mathematics from the University of Minnesota Twin Cities, Andrew earned his doctorate in Structural Biology from Stanford University in 2009.
Andrew was selected for the 2016 Forbes “30 under 30” list, and is the recipient of a Smith Family Award for Excellence in Biomedical Research, a Klingenstein-Simons Fellowship, and an NIH Director’s Early Independence Award. He is a 2016 Vallee Scholar, which provides grants to outstanding young independent researchers, and is a recipient of a 2017 Sloan Research Fellowship, through which the Alfred P. Sloan Foundation honors early-career scholars and provides funding for their research.